Abstract
Nature provides science and society with a virtually unlimited supply of structurally diverse and biologically active molecules; the natural products. While some are directly useful in commercial applications, others are valuable for studying and understanding biological phenomena at the molecular level. An example is the signaling of nerve cells, which has been explored in considerable detail using a number of bioactive natural products. This review concerns primarily a part of the GABA inhibitory system of the central nervous system, the GABAA receptors, and natural products that have been reported to affect GABAA receptors in various ways. As the major inhibitory neurotransmittor, GABA plays a central role in the function of the central nervous system and modulates the activities of all neurons. Malfunctions in the GABA-operated systems cause a number of severe mental disorders, which consequently, at least in theory, can be treated with drugs. The natural products discussed in this review, acting on the GABAA receptors, are divided into the three main classes; terpenoids, polyacetylenic alcohols, and flavonoids. In addition, in a second part of the review, it is exemplified how knowledge about quantitative structure-activity relationships for a molecular target can be used to design novel, potent and selective compounds targeting the benzodiazepine binding site of the GABAA receptors.
Keywords: GABA, receptor, benzodiazepine binding site, terpenes, polyacetylenes, flavonoids, SAR, pharmacophore model, natural products, molecular biology
Current Drug Targets
Title: Modulation of GABAA Receptors by Natural Products and the Development of Novel Synthetic Ligands for the Benzodiazepine Binding Site
Volume: 12 Issue: 11
Author(s): Jakob Nilsson and Olov Sterner
Affiliation:
Keywords: GABA, receptor, benzodiazepine binding site, terpenes, polyacetylenes, flavonoids, SAR, pharmacophore model, natural products, molecular biology
Abstract: Nature provides science and society with a virtually unlimited supply of structurally diverse and biologically active molecules; the natural products. While some are directly useful in commercial applications, others are valuable for studying and understanding biological phenomena at the molecular level. An example is the signaling of nerve cells, which has been explored in considerable detail using a number of bioactive natural products. This review concerns primarily a part of the GABA inhibitory system of the central nervous system, the GABAA receptors, and natural products that have been reported to affect GABAA receptors in various ways. As the major inhibitory neurotransmittor, GABA plays a central role in the function of the central nervous system and modulates the activities of all neurons. Malfunctions in the GABA-operated systems cause a number of severe mental disorders, which consequently, at least in theory, can be treated with drugs. The natural products discussed in this review, acting on the GABAA receptors, are divided into the three main classes; terpenoids, polyacetylenic alcohols, and flavonoids. In addition, in a second part of the review, it is exemplified how knowledge about quantitative structure-activity relationships for a molecular target can be used to design novel, potent and selective compounds targeting the benzodiazepine binding site of the GABAA receptors.
Export Options
About this article
Cite this article as:
Nilsson Jakob and Sterner Olov, Modulation of GABAA Receptors by Natural Products and the Development of Novel Synthetic Ligands for the Benzodiazepine Binding Site, Current Drug Targets 2011; 12 (11) . https://dx.doi.org/10.2174/138945011798109509
DOI https://dx.doi.org/10.2174/138945011798109509 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Investigating Mitochondrial Dysfunction to Increase Drug Safety in the Pharmaceutical Industry
Current Drug Targets Inhibitors of Glycine Transporter-1: Potential Therapeutics for the Treatment of CNS Disorders
Current Topics in Medicinal Chemistry The Medical Implications of Gastrointestinal Vagal Afferent Pathways in Nausea and Vomiting
Current Pharmaceutical Design Omega-3 Fatty Acids and their Role in Central Nervous System - A Review
Current Medicinal Chemistry Study of Convolvulus pluricaulis for Antioxidant and Anticonvulsant Activity
Central Nervous System Agents in Medicinal Chemistry HIV-1 Tat-Induced Changes in Synaptically-Driven Network Activity Adapt During Prolonged Exposure
Current HIV Research Carbonic Anhydrase Inhibitors
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Neuropathic Pain and Lung Delivery of Nanoparticulate Drugs: An Emerging Novel Therapeutic Strategy
CNS & Neurological Disorders - Drug Targets Purine Ionotropic (P2X) Receptors
Current Pharmaceutical Design Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders
CNS & Neurological Disorders - Drug Targets Neuroimaging of the Serotonin Transporter: Possibilities and Pitfalls
Current Psychiatry Reviews 5-HT3 Receptors: A Potential Therapeutic Target for Epilepsy
Current Neuropharmacology A Study of Applications of Machine Learning Based Classification Methods for Virtual Screening of Lead Molecules
Combinatorial Chemistry & High Throughput Screening Applications of PET and SPECT in Patients with Autism Spectrum Disorder
Current Medical Imaging EEG Source Localization Using a Genetic Algorithm-Based Artificial Neural Network
Recent Patents on Biomedical Engineering (Discontinued) Recent Development in Substituted Benzothiazole as an Anticonvulsant Agent
Mini-Reviews in Medicinal Chemistry Inhibitors of HDACs - Effective Drugs Against Cancer?
Current Cancer Drug Targets PET/MR Tomographs: A Review with Technical, Radiochemical and Clinical Perspectives
Current Radiopharmaceuticals Nanotechnological Advances in the Treatment of Epilepsy
CNS & Neurological Disorders - Drug Targets Update on Medical and Surgical Management of Intracerebral Hemorrhage
Reviews on Recent Clinical Trials